Venezuela will receive 6.2 million doses of COVID-19 vaccines through the global COVAX initiative in the coming days, Reuters news agency reported on Monday.
President Nicolas Maduro had reportedly given COVAX an "ultimatum" to send the doses or return the funds Venezuela has already paid.
This announcement comes after the GAVI alliance, which co-runs the COVAX facility along with the World Health Organisation (WHO), said in early July 2021 that COVAX had received payments from Venezuela after the country's officials said some payments were blocked by a bank due to US sanctions.
According to the Pan-American Health Organisation (PAHO), the regional arm of the WHO, Venezuela will receive doses of Chinese pharmaceutical company Sinopharm (HKG:1099) and biopharmaceutical Sinovac Biotech Ltd(Nasdaq:SVA) vaccines through the initiative.
The country has so far been administering Sinopharm, Russia's Sputnik-V and Cuba's Abdala COVID-19 vaccines, Reuters added.
GSK secures EU approval for fully liquid Menveo vaccine
Scancell reports promising SCOPE trial data for SCIB1 in advanced melanoma
Transgene teams up with ProBioGen for individualised cancer vaccines
Bio-Works Technologies AB secures LOI for vaccine manufacturing product
LakeShore Biopharma's Phase III YSJA Rabies Vaccine clinical trial receives Chinese NMPA approval
Merck's CAPVAXIVE shows promising immune responses in adults at risk of pneumococcal disease
GSK PLC announces acceptance of NDA for gepotidacin by US FDA